These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 32390266)

  • 1. Outpatient fluoroquinolone prescribing patterns before and after US FDA boxed warning.
    Bratsman A; Mathias K; Laubscher R; Grigoryan L; Rose S
    Pharmacoepidemiol Drug Saf; 2020 Jun; 29(6):701-707. PubMed ID: 32390266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of FDA Boxed Warning on Prescribing Patterns of Fluoroquinolones for Uncomplicated Urinary Tract Infections.
    Cowart K; Worley M; Rouby NE; Sando K
    Ann Pharmacother; 2019 Dec; 53(12):1192-1199. PubMed ID: 31319681
    [No Abstract]   [Full Text] [Related]  

  • 3. Association of Fluoroquinolone Prescribing Rates With Black Box Warnings from the US Food and Drug Administration.
    Sankar A; Swanson KM; Zhou J; Jena AB; Ross JS; Shah ND; Karaca-Mandic P
    JAMA Netw Open; 2021 Dec; 4(12):e2136662. PubMed ID: 34851398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of US Food and Drug Administration Removal of Indications for Use of Oral Quinolones With Prescribing Trends.
    Tran PT; Antonelli PJ; Hincapie-Castillo JM; Winterstein AG
    JAMA Intern Med; 2021 Jun; 181(6):808-816. PubMed ID: 33871571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of FDA black box warning on fluoroquinolone and alternative antibiotic use in southeastern US hospitals.
    Yarrington ME; Anderson DJ; Dodds Ashley E; Jones T; Davis A; Johnson M; Lokhnygina Y; Sexton DJ; Moehring RW
    Infect Control Hosp Epidemiol; 2019 Nov; 40(11):1297-1300. PubMed ID: 31474240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current prescribing practices and guideline concordance for the treatment of uncomplicated urinary tract infections in women.
    Langner JL; Chiang KF; Stafford RS
    Am J Obstet Gynecol; 2021 Sep; 225(3):272.e1-272.e11. PubMed ID: 33848538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outpatient Fluoroquinolone Use in Children, 2000-2018.
    Ross RK; Gerber JS; Willis ZI; Hersh AL; Kinlaw AC
    J Pediatric Infect Dis Soc; 2021 May; 10(5):576-585. PubMed ID: 33377490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indications for Systemic Fluoroquinolone Therapy in Europe and Prevalence of Primary-Care Prescribing in France, Germany and the UK: Descriptive Population-Based Study.
    Morales DR; Slattery J; Pinheiro L; Kurz X; Hedenmalm K
    Clin Drug Investig; 2018 Oct; 38(10):927-933. PubMed ID: 30143952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternatives to fluoroquinolones.
    Med Lett Drugs Ther; 2016 Jun; 58(1496):75-6. PubMed ID: 27249097
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of the US Food and Drug Administration warning regarding increased risk of aortic aneurysms or aortic dissections on fluoroquinolone prescribing trends.
    Rizk JG; Slejko JF; Heil EL; Seo D; Qato DM
    BMJ Open Qual; 2024 Jul; 13(3):. PubMed ID: 39053916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opportunities to Improve Fluoroquinolone Prescribing in the United States for Adult Ambulatory Care Visits.
    Kabbani S; Hersh AL; Shapiro DJ; Fleming-Dutra KE; Pavia AT; Hicks LA
    Clin Infect Dis; 2018 Jun; 67(1):134-136. PubMed ID: 29373664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDA and the safe and appropriate antibiotic use of fluoroquinolones.
    Tillotson GS
    Lancet Infect Dis; 2016 Mar; 16(3):e11-2. PubMed ID: 26973315
    [No Abstract]   [Full Text] [Related]  

  • 13. Failure of a Best Practice Alert to Reduce Antibiotic Prescribing Rates for Acute Sinusitis Across an Integrated Health System in the Midwest.
    Hansen MJ; Carson PJ; Leedahl DD; Leedahl ND
    J Manag Care Spec Pharm; 2018 Feb; 24(2):154-159. PubMed ID: 29384025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. National patterns in the treatment of urinary tract infections in women by ambulatory care physicians.
    Huang ES; Stafford RS
    Arch Intern Med; 2002 Jan; 162(1):41-7. PubMed ID: 11784218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In the Line of Fire: Should Urologists Stop Prescribing Fluoroquinolones as Default?
    Bonkat G; Wagenlehner F
    Eur Urol; 2019 Feb; 75(2):205-207. PubMed ID: 30471884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of outpatient fluoroquinolone prescribing with the National Medical Products Administration announcements of label changes in China.
    Zhao H; Sun Y; Yao X; Shen P; Lin H; Zhan S
    Expert Rev Anti Infect Ther; 2024 Nov; 22(11):1007-1015. PubMed ID: 38881100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends and Frequencies of Antibiotic Prescriptions for Acute Sinusitis Outpatient Visits in Adults.
    Jin V; Chiu R; Patel M; Zhu A; Perez B; Lee V
    Laryngoscope; 2024 Jun; 134(6):2622-2625. PubMed ID: 38102927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic Use in Hospital Urinary Tract Infections After FDA Regulation.
    Brant A; Lewicki P; Wu X; Sze C; Johnson JP; Ponsky L; Kaye KS; Wise GJ; Shoag JE
    J Gen Intern Med; 2024 Jun; 39(8):1414-1422. PubMed ID: 38148474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outpatient Fluoroquinolone Prescription Fills in the United States, 2014 to 2020: Assessing the Impact of Food and Drug Administration Safety Warnings.
    Buehrle DJ; Wagener MM; Clancy CJ
    Antimicrob Agents Chemother; 2021 Jun; 65(7):e0015121. PubMed ID: 33875430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Empiric antibiotic therapy in acute uncomplicated urinary tract infections and fluoroquinolone resistance: a prospective observational study.
    Aypak C; Altunsoy A; Düzgün N
    Ann Clin Microbiol Antimicrob; 2009 Oct; 8():27. PubMed ID: 19852849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.